Nkarta, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
NKTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
1150 Veterans Boulevard, South San Francisco, CA

Insiders trading volume in the past year

Nkarta, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ra Capital Management, L.P. Director, 10%+ Owner $131M +$60M +85.1% Jun 13, 2024
Simeon George Director $4.52M +$20M Jun 13, 2024
James Trager Chief Scientific Officer $845K -$52.3K -5.82% Jun 18, 2024
Paul J. Hastings Chief Executive Officer, Director $704K -$48.1K -6.4% Jan 15, 2025
Nadir Mahmood President $477K Jan 3, 2025
David Shook Chief Medical Officer, Head of Research & Development $420K -$21.6K -4.88% Jan 15, 2025
Alicia Hager Chief Legal Officer $323K -$52.3K -13.9% Jan 15, 2025
Ralph Brandenberger Chief Technical Officer $275K -$122K -30.8% Jan 15, 2025
Alyssa Levin Chief Financial and Business Officer $226K -$12.8K -5.38% Jan 15, 2025
Kanya Rajangam Chief Medical Officer $112K Jan 14, 2022
Leone D. Patterson Director Jun 13, 2024
Michael Dybbs Director Jun 13, 2024
Angela Thedinga Director Jun 13, 2024
Laura Shawver Director Jun 8, 2022
Zachary Scheiner Director Jun 13, 2024
Fouad Oscar Azzam Director Jun 7, 2023
Ali Behbahani Director Jun 13, 2024
Tiba Aynechi Director Jun 8, 2022
George Vratsanos Director Jun 13, 2024

Recent Insider Transactions by Companies or Individuals for Nkarta, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.